These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 441512)

  • 1. Prevention by coenzyme Q10 of the electrocardiographic changes induced by adriamycin in rats.
    Choe JY; Combs AB; Folkers K
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):199-202. PubMed ID: 441512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction by coenzyme Q10 of the acute toxicity of adriamycin in mice.
    Combs AB; Choe JY; Truong DH; Folkers K
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):565-8. PubMed ID: 928953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat.
    Folkers K; Choe JY; Combs AB
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5178-80. PubMed ID: 283424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic cardiotoxicity of anthracycline derivatives and possible prevention by coenzyme Q10].
    Tajima M
    Gan No Rinsho; 1984 Jul; 30(9 Suppl):1211-6. PubMed ID: 6471423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of 2,3-dimethoxy-5-methyl-6-(10'-hydroxydecyl)-1,4-benzoquinone (CV-2619) on adriamycin-induced ECG abnormalities and myocardial energy metabolism in spontaneously hypertensive rats].
    Shimamoto N; Tanabe M; Hirata M
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):307-15. PubMed ID: 7152396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases].
    Wang SQ
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyopathy and other chronic toxic effects induced in rabbits by doxorubicin and possible prevention by coenzyme Q10.
    Domae N; Sawada H; Matsuyama E; Konishi T; Uchino H
    Cancer Treat Rep; 1981; 65(1-2):79-91. PubMed ID: 7226168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coenzyme Q10 and adriamycin toxicity in mice.
    Shaeffer J; El-Mahdi AM; Nichols RK
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):309-15. PubMed ID: 7414051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10.
    Cortes EP; Gupta M; Chou C; Amin VC; Folkers K
    Cancer Treat Rep; 1978 Jun; 62(6):887-91. PubMed ID: 667863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of biological membrane stabilizing drugs (coenzyme Q10, dextran sulfate and reduced glutathione) on adriamycin (doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice].
    Shinozawa S; Kawasaki H; Gomita Y
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):93-8. PubMed ID: 8546477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of exogenous coenzyme Q against damage by adriamycin in perfused rat liver.
    Valls V; Castelluccio C; Fato R; Genova ML; Bovina C; Saez G; Marchetti M; Parenti Castelli G; Lenaz G
    Biochem Mol Biol Int; 1994 Jul; 33(4):633-42. PubMed ID: 7981650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the combined and separate administration of doxorubicin and coenzyme Q10 on mouse cardiac enzymes.
    Choe JY; Combs AB; Saji S; Folkers K
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):595-8. PubMed ID: 451343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of ouabain on adriamycin-induced cardiovascular anomalies in chick embryos.
    Takagi Y; Bruyere HJ; Nishikawa T
    Teratology; 1989 Jun; 39(6):573-80. PubMed ID: 2772843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioenergetics in clinical medicine: prevention by forms of coenzyme Q of the inhibition by adriamycin of coenzyme Q10-enzymes in mitochondria of the myocardium.
    Kishi T; Watanabe T; Folkers K
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4653-6. PubMed ID: 1070015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes.
    Kishi T; Folkers K
    Cancer Treat Rep; 1976 Mar; 60(3):223-4?U9ENG. PubMed ID: 1260779
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of selenium, WR-2721, and their combination in the prevention of adriamycin-induced cardiotoxicity in rats.
    Dobrić S; Dragojević-Simić V; Bokonjić D; Milovanović S; Marincić D; Jović P
    J Environ Pathol Toxicol Oncol; 1998; 17(3-4):291-9. PubMed ID: 9726805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Models for clinical disease. I. Biochemical cardiotoxicity of a coenzyme Q10-inhibitor in rats.
    Combs AB; Kishi T; Porter TH; Folkers K
    Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):333-9. PubMed ID: 1257616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants.
    Sugino K; Dohi K; Yamada K; Kawasaki T
    Surgery; 1989 Feb; 105(2 Pt 1):200-6. PubMed ID: 2916180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].
    Tsubaki K; Horiuchi A; Kitani T; Taniguchi N; Masaoka T; Shibata H; Yonezawa T; Tsubakio T; Kawagoe H; Shinohara Y
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1420-7. PubMed ID: 6742867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.